$PNYG
Pony Group Inc.

2023 Q2 Form 10-Q Financial Statement

#000121390023039787 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $47.23K $56.17K $29.87K
YoY Change 99.31% 88.03% 143.44%
Cost Of Revenue $20.87K $24.60K $24.82K
YoY Change 208.27% -0.87% -21.08%
Gross Profit $26.36K $31.56K $5.050K
YoY Change 55.73% 524.99% -126.33%
Gross Profit Margin 55.82% 56.19% 16.91%
Selling, General & Admin $88.54K $114.4K
YoY Change -22.57% 393.74%
% of Gross Profit 280.53% 2264.36%
Research & Development $0.00 $7.070K
YoY Change -100.0%
% of Gross Profit 0.0% 140.0%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $71.87K $88.54K $121.4K
YoY Change -46.35% -27.08% 424.27%
Operating Profit -$45.51K -$56.97K -$116.4K
YoY Change -61.11% -51.04% 174.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$156.00 $79.00 $30.00
YoY Change -132.98% 163.33% -130.0%
Pretax Income -$45.36K -$57.05K -$116.3K
YoY Change -61.4% -50.96% 174.13%
Income Tax
% Of Pretax Income
Net Earnings -$45.36K -$57.05K -$116.3K
YoY Change -61.4% -50.96% 174.13%
Net Earnings / Revenue -96.04% -101.58% -389.49%
Basic Earnings Per Share $0.00 -$0.01 -$0.01
Diluted Earnings Per Share $0.00 -$0.01 -$10.12K
COMMON SHARES
Basic Shares Outstanding 11.50M shares 11.50M shares 11.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.54K $146.5K
YoY Change -82.56% -44.69%
Cash & Equivalents $31.68K $25.54K $146.5K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $8.725K $14.44K $20.10K
Other Receivables $16.82K $26.50K $9.330K
Total Short-Term Assets $66.22K $75.47K $175.9K
YoY Change -20.61% -57.09% -41.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $66.22K $75.47K $175.9K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $66.22K $75.47K $175.9K
YoY Change -20.61% -57.09% -41.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.78K $34.79K $19.57K
YoY Change 1.56% 77.79% 36.09%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $509.0K $489.0K $395.7K
YoY Change 23.86% 23.59% 15.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $509.0K $489.0K $395.7K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $509.0K $489.0K $395.7K
YoY Change 23.86% 23.59% 15.0%
SHAREHOLDERS EQUITY
Retained Earnings -$651.8K -$606.5K
YoY Change 26.77%
Common Stock $11.50K $11.50K $11.50K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$442.8K -$413.5K -$219.8K
YoY Change
Total Liabilities & Shareholders Equity $66.22K $75.47K $175.9K
YoY Change -20.61% -57.09% -41.12%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$45.36K -$57.05K -$116.3K
YoY Change -61.4% -50.96% 174.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$32.45K -$116.2K
YoY Change -72.07% 246.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.085K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.085K -2.920K
YoY Change -411.13% -122.31%
NET CHANGE
Cash From Operating Activities -$32.45K -116.2K
Cash From Investing Activities
Cash From Financing Activities $9.085K -2.920K
Net Change In Cash -$23.36K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$32.45K -$116.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-234358
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Pony Group Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3532241
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Engineer Experiment Building
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
A202 7 Gaoxin South Avenue
CY2023Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CN
CY2023Q1 dei City Area Code
CityAreaCode
+86
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
755 86665622
CY2023Q1 dei Security12b Title
Security12bTitle
None
CY2023Q1 dei Trading Symbol
TradingSymbol
N/A
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11500000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25542 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49803 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14435 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10723 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
26496 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
285 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
8998 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
8998 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
75471 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
69809 usd
CY2023Q1 us-gaap Assets
Assets
75471 usd
CY2022Q4 us-gaap Assets
Assets
69809 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
34793 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31343 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
387838 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
378753 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
66334 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15257 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
488965 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
425353 usd
CY2023Q1 us-gaap Liabilities
Liabilities
488965 usd
CY2022Q4 us-gaap Liabilities
Liabilities
425353 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11500000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11500000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11500000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11500000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
11500 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11500 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
5461 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
6360 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-606455 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-549404 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-413494 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-355544 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75471 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69809 usd
CY2023Q1 us-gaap Revenues
Revenues
56166 usd
CY2022Q1 us-gaap Revenues
Revenues
29868 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
24604 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
24824 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
31562 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
5044 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88535 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114348 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7070 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
88535 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
121418 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-56973 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-116374 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
79 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-57052 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-116340 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-899 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-442 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57951 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116782 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.005
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-355544 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-899 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-57052 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-413495 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-102984 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-442 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-116340 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-219766 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-57052 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-116340 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3712 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27734 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
26211 usd
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
24 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3450 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17484 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
51078 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-10080 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32447 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-116194 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9085 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-2915 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9085 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2915 usd
CY2023Q1 pginc Effects Of Currency Translation On Cash
EffectsOfCurrencyTranslationOnCash
899 usd
CY2022Q1 pginc Effects Of Currency Translation On Cash
EffectsOfCurrencyTranslationOnCash
442 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-24261 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-119551 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49803 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266011 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25542 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146460 usd
CY2019Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
10000 shares
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14435 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10723 usd
CY2023Q1 us-gaap Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
1 pure
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.206 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Foreign
EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign
0.165 pure
CY2023Q1 pginc Operating Loss
OperatingLoss
-57052 usd
CY2022Q1 pginc Operating Loss
OperatingLoss
-116340 usd
CY2023Q1 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
-606455 usd
CY2022Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
-549404 usd
CY2023Q1 pginc Us Legal And Audit Cost Incurred
USLegalAndAuditCostIncurred
310580 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Amount of receivable from shareholders due to the company declared a 6,000 to 1 stock split.
CY2023Q1 us-gaap Share Price
SharePrice
0.001
CY2023Q1 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
8998 usd
CY2023Q1 us-gaap Related Party Tax Expense Due From Affiliates Current
RelatedPartyTaxExpenseDueFromAffiliatesCurrent
8998 usd
CY2022 us-gaap Related Party Tax Expense Due From Affiliates Current
RelatedPartyTaxExpenseDueFromAffiliatesCurrent
8998 usd
CY2023Q1 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
387838 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
378753 usd
CY2023Q1 us-gaap Percentage Of Unamortized Film Costs
PercentageOfUnamortizedFilmCosts
0.237 pure
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.005
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.010
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001784058

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-23-039787-index-headers.html Edgar Link pending
0001213900-23-039787-index.html Edgar Link pending
0001213900-23-039787.txt Edgar Link pending
0001213900-23-039787-xbrl.zip Edgar Link pending
f10q0323ex31-1_ponygroup.htm Edgar Link pending
f10q0323ex32-1_ponygroup.htm Edgar Link pending
f10q0323_ponygroup.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pginc-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pginc-20230331_cal.xml Edgar Link unprocessable
pginc-20230331_def.xml Edgar Link unprocessable
pginc-20230331_lab.xml Edgar Link unprocessable
pginc-20230331_pre.xml Edgar Link unprocessable
f10q0323_ponygroup_htm.xml Edgar Link completed